Svar Life Science

Case Story

How Svar CRO Supports Alentis Therapeutics' Clinical Success

In the complex landscape of drug development, having a reliable and trusted partner can make all the difference. Discover how Svar Life Science CRO partners with Alentis Therapeutics to help drive their groundbreaking advancements in oncology and fibrosis treatments.

Since 2020 Svar Life Science CRO has been working with Alentis Therapeutics, a Swiss biotech company known for groundbreaking work in oncology and fibrosis, supporting their work in the development of anti-Claudin-1 (CLDN1) therapies.

Over the course of more than 40 studies, the role of Svar has extended beyond mere execution, acting as a trusted collaborator, supporting Alentis in navigating complex immunogenicity, pharmacokinetic, and biomarker studies with precision and speed, ultimately helping inform critical strategic decision.

Download the full article to know how Svar supports Alentis’ progress.


 

Case Story

How Svar CRO Supports Alentis Therapeutics' Clinical Success

In the complex landscape of drug development, having a reliable and trusted partner can make all the difference. Discover how Svar Life Science CRO partners with Alentis Therapeutics to help drive their groundbreaking advancements in oncology and fibrosis treatments.

Since 2020 Svar Life Science CRO has been working with Alentis Therapeutics, a Swiss biotech company known for groundbreaking work in oncology and fibrosis, supporting their work in the development of anti-Claudin-1 (CLDN1) therapies.

Over the course of more than 40 studies, the role of Svar has extended beyond mere execution, acting as a trusted collaborator, supporting Alentis in navigating complex immunogenicity, pharmacokinetic, and biomarker studies with precision and speed, ultimately helping inform critical strategic decision.

Download the full article to know how Svar supports Alentis’ progress.


 

Get exclusive insights from:

  • Markus Meyer, PhD, Chief Operating Officer, Alentis Therapeutics
  • Anna Karaszewska, Product Manager, CRO Services, Svar Life Science
  • Barbara Lettiero, PhD, Senior Scientist & Project Manager, Svar Life Science

Learn how Svar helps Alentis:

  • Build a highly translational PK model to define the proper doses for clinical studies
  • Assess the immunogenic potential of antibodies
  • Establish knowledge for other drug candidates
  • Advance the clinical development of the antibodies to clinical Phase 2

Please complete the form
to access the Case Study